US EditionJudge Refuses to Block Sending Abortion Pill by Mail for Now, but Says FDA Must Finish Review
The judge said the FDA should finish its safety review before the court decides whether to curb telehealth abortion access.
- On Tuesday, U.S. District Judge David Joseph refused to block the mailing of mifepristone prescriptions, denying Louisiana's immediate request to halt the practice while the legal challenge proceeds.
- Louisiana Attorney General Liz Murrill filed the lawsuit arguing that mail-order prescriptions undermine the state's abortion ban, one of 13 states that bar abortion at all stages of pregnancy.
- One study found that by the end of 2024, one-fourth of abortions were accessed by telehealth—a fivefold increase in two years—making mifepristone central to post-Roe legal battles.
- Murrill is pursuing criminal cases against two doctors in California and New York for mailing pills to Louisiana, though those states have not extradited the physicians to face charges.
- Judge Joseph warned that his decision is not indefinite, ordering the Food and Drug Administration to update the court on its safety review within six months.
28 Articles
28 Articles
Abortion pill mifepristone stays available by mail for now as FDA faces 6-month review deadline – Democratic Accent
A federal judge allowed the abortion pill mifepristone to continue being distributed by mail nationwide for now, but warned the Biden-era policy could soon face major legal changes as a Food and Drug Administration (FDA) safety review of the drug unfolds. The legal challenge to the U.S. Food and Drug Administration’s January 2023 Risk Evaluation and Mitigation Strategy (REMS) seeks to end the “certified pharmacies” regulation that allows for the…
Abortion pill mifepristone stays available by mail for now as FDA faces 6-month review deadline
Mifepristone will continue to be distributed by mail after a federal judge denied Louisiana attorney general's injunction request and ordered the FDA to finish its safety review.
Judge Doesn't Stop Mail-Order Abortions, Lets FDA Finish Safety Review
A federal judge scolded the Food and Drug Administration over its decision to loosen safety restrictions on mailing the dangerous abortion pill mifepristone that has killed millions of babies and injured countless thousands of women. But the judge refused to immediately block the practice, instead pausing the case and giving the agency time to complete a review of the drug. U.S. District Judge David Joseph, a Trump appointee in Lafayette, Louisi…
Judge pauses Louisiana's challenge to FDA abortion drug rule
A federal judge on Tuesday put on hold the state of Louisiana's lawsuit seeking to limit access to the abortion pill mifepristone nationwide while President Donald Trump's administration conducts a review of the drug's safety.
Telehealth abortion will remain available for now, after a federal judge's ruling
The abortion pill mifepristone must undergo a safety review by the FDA, the judge said. Louisiana's case seeking to ban its use through telemedicine will proceed after that review.
Associated Press News
Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review
A federal judge has ruled that the abortion drug mifepristone can continue to be dispensed by mail to people with prescriptions, at least for now. But U.S.
Coverage Details
Bias Distribution
- 46% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
